199 related articles for article (PubMed ID: 33240404)
1. Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?
Benavent D; Plasencia-Rodríguez C; Franco-Gómez K; Nieto R; Monjo-Henry I; Peiteado D; Balsa A; Navarro-Compán V
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20971889. PubMed ID: 33240404
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of possible HLA biomarkers in axial spondyloarthritis beyond HLA-B27 positivity.
Šegota A; Schnurrer-Luke-Vrbanić T; Avancini-Dobrović V; Mirić F
Rheumatol Int; 2023 Nov; 43(11):2073-2079. PubMed ID: 37450032
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials.
Kavanaugh A; Baraliakos X; Gao S; Chen W; Sweet K; Chakravarty SD; Song Q; Shawi M; Rahman P
Adv Ther; 2023 May; 40(5):2439-2456. PubMed ID: 36995469
[TBL] [Abstract][Full Text] [Related]
4. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
Regierer AC; Weiß A; Proft F; Baraliakos X; Behrens F; Poddubnyy D; Schett G; Lorenz HM; Worsch M; Strangfeld A
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36898762
[TBL] [Abstract][Full Text] [Related]
5. Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study.
Benavent D; Plasencia C; Poddubnyy D; Kishimoto M; Proft F; Sawada H; López-Medina C; Dougados M; Navarro-Compán V
Semin Arthritis Rheum; 2021 Aug; 51(4):766-774. PubMed ID: 34144387
[TBL] [Abstract][Full Text] [Related]
6. Treat-to-target in real-life psoriatic arthritis patients: achieving minimal disease activity with bDMARDs/tsDMARDs and potential barriers.
Ortolan A; Lorenzin M; Cozzi G; Scagnellato L; Favero M; Striani G; Vio S; Scapin V; De Conti G; Doria A; Ramonda R
Semin Arthritis Rheum; 2023 Oct; 62():152237. PubMed ID: 37453183
[TBL] [Abstract][Full Text] [Related]
7. Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study.
Benavent D; Muñoz-Fernández S; De la Morena I; Fernández-Nebro A; Marín-Corral J; Castillo Rosa E; Taberna M; Sanabra C; Sastre C;
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231220818. PubMed ID: 38146537
[TBL] [Abstract][Full Text] [Related]
8. Axial Disease in Psoriatic Arthritis: how can we Define it, and does it have an Impact on Treatment?
Lopez-Medina C; Ziade N
Mediterr J Rheumatol; 2022 Mar; 33(Suppl 1):142-149. PubMed ID: 36127925
[TBL] [Abstract][Full Text] [Related]
9. Dactylitis Is Associated With More Severe Axial Joint Damage and Higher Disease Activity in Axial Psoriatic Arthritis.
Li SS; Du N; He SH; Liang X; Li TF
J Rheumatol; 2022 Sep; 49(9):1012-1019. PubMed ID: 35501145
[TBL] [Abstract][Full Text] [Related]
10. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
[TBL] [Abstract][Full Text] [Related]
11. Comparison of clinical characteristics between adult-onset and juvenile-onset non-radiographic axial spondyloarthritis in Chinese patients: results from the COCAS cohort.
Huang SX; Li HG; Liang HJ; Wang DM; Peng JH; Shen FC; Li WP; Lin L; Xiao ZY; Hou ZD
Eur J Med Res; 2023 Sep; 28(1):388. PubMed ID: 37770993
[TBL] [Abstract][Full Text] [Related]
12. Disease characteristics, pathogenesis, and treatment controversies of axial psoriatic arthritis.
Yousif P; Nahra V; Khan MA; Magrey M
Joint Bone Spine; 2024 Jan; 91(1):105625. PubMed ID: 37495073
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.
Klemm P; Hudowenz O; Asendorf T; Dischereit G; Müller-Ladner U; Lange U; Tarner IH
Clin Rheumatol; 2020 May; 39(5):1513-1520. PubMed ID: 31916106
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Chandran V
Curr Opin Rheumatol; 2019 Jul; 31(4):329-334. PubMed ID: 31135567
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.
Zeidler HK
J Clin Rheumatol; 2022 Jan; 28(1):38-43. PubMed ID: 34941618
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Possibility of Axial Psoriatic Arthritis Patients Meeting Classification Criteria for Axial Spondyloarthritis and Ankylosing Spondylitis.
Gubar EE; Korotaeva TV; Korsakova YL; Loginova EY; Smirnov AV; Sukhinina AV; Urumova MM; Glukhova SI
Dokl Biochem Biophys; 2024 Jun; ():. PubMed ID: 38861144
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study.
Haroon M; Ahmad M; Baig MN; Mason O; Rice J; FitzGerald O
Arthritis Res Ther; 2018 Apr; 20(1):73. PubMed ID: 29665824
[TBL] [Abstract][Full Text] [Related]
18. Dosage reduction and discontinuation of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: protocol for a pragmatic, randomised controlled trial (the BIOlogical Dose OPTimisation (BIODOPT) trial).
Uhrenholt L; Schlemmer A; Hauge EM; Christensen R; Dreyer L; Suarez-Almazor ME; Kristensen S
BMJ Open; 2019 Jul; 9(7):e028517. PubMed ID: 31292181
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry.
Ciurea A; Götschi A; Kissling S; Bernatschek A; Bürki K; Exer P; Nissen MJ; Möller B; Scherer A; Micheroli R
RMD Open; 2023 Jun; 9(2):. PubMed ID: 37277211
[TBL] [Abstract][Full Text] [Related]
20. Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
Benavent D; Franco-Gómez K; Plasencia-Rodriguez C; Novella-Navarro M; Bogas P; Nieto R; Monjo I; Nuño L; Villalba A; Peiteado D; Balsa A; Navarro-Compán V
BMJ Open; 2022 Apr; 12(4):e057850. PubMed ID: 35487753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
